ENTRY       D05393                      Drug
NAME        Pegsunercept (USAN)
FORMULA     C502H758N154O165S16
EXACT_MASS  12095.1188
MOL_WEIGHT  12103.3627
SEQUENCE    MDSVCPQGKY IHPQNNSICC TKCHKGTYLY NDCPGPGQDT DCRECESGSF TASENHLRHC
            LSCSKCRKEM GQVEISSCTV DRDTVCGCRK NQYRHYWSEN LFQCFN
            (Disulfide bridge: 5-19, 20-33, 23-42, 63-78, 66-86, 88-104)
  TYPE      Peptide
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG01936  TNF inhibitor
EFFICACY    Anti-inflammatory, TNF-alpha inhibitor
COMMENT     a PEGylated protein (a polyethylene-glycol-modified soluble tumor-necrosis-factor receptor type 1)
            Treatment of inflammatory and autoimmune conditions (e.g. rheumatoid arthritis, Crohn's disease) (binds and therapy inhibits the inflammatory activity of tumor necrosis factor)
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  PATHWAY   hsa04010(7124)  MAPK signaling pathway
            hsa04060(7124)  Cytokine-cytokine receptor interaction
            hsa04064(7124)  NF-kappa B signaling pathway
            hsa04150(7124)  mTOR signaling pathway
            hsa04350(7124)  TGF-beta signaling pathway
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG01936  TNF inhibitor
                D05393  Pegsunercept
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D05393  Pegsunercept (USAN)
DBLINKS     CAS: 330988-75-5
            PubChem: 47207069
///
